Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
89.69
+1.58 (1.79%)
Jun 26, 2026, 4:00 PM EDT - Market closed

PBE Holdings List

Jun 25, 2026
No.SymbolName WeightShares
1VRTXVertex Pharmaceuticals Incorporated5.04%28,896
2AMGNAmgen Inc.4.81%37,497
3BIIBBiogen Inc.4.79%65,241
4RPRXRoyalty Pharma plc4.65%233,880
5ALNYAlnylam Pharmaceuticals, Inc.4.54%42,629
6REGNRegeneron Pharmaceuticals, Inc.4.47%19,849
7UTHRUnited Therapeutics Corporation4.30%21,777
8GILDGilead Sciences, Inc.4.24%94,196
9TECHBio-Techne Corporation3.68%143,235
10VCYTVeracyte, Inc.3.31%155,417
11CDNACareDx, Inc.3.23%318,987
12RGENRepligen Corporation3.15%59,649
13PTCTPTC Therapeutics, Inc.3.12%101,567
14VCELVericel Corporation3.06%196,482
15PTGXProtagonist Therapeutics, Inc.3.06%68,723
16ILMNIllumina, Inc.3.05%47,313
17BCRXBioCryst Pharmaceuticals, Inc.2.92%811,213
18ACADACADIA Pharmaceuticals Inc.2.79%323,188
19INCYIncyte Corporation2.77%70,762
20QGENQiagen N.V.2.74%193,331
21BMRNBioMarin Pharmaceutical Inc.2.71%129,935
22EXELExelixis, Inc.2.66%137,474
23HALOHalozyme Therapeutics, Inc.2.64%99,985
24NBIXNeurocrine Biosciences, Inc.2.63%44,121
25ANABAnaptysBio, Inc.2.58%118,937
As of Jun 25, 2026